News

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Some say that Ozempic can lead to surprise pregnancies, referred to as "Ozempic babies," by increasing fertility. Learn what ...
There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...
Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...
Mumbai-based Supriya Lifescience is betting on a steady growth trajectory over the next few years, with Managing Director Saloni Wagh guiding for over 20% revenue growth annually. “That’s the guidance ...
The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...
"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...
Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.
Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse ...